Security record · archived quarter
APGE
Apogee Therapeutics, Inc. · Healthcare · Biotechnology
16Tracked holders
+1Δ holders
22.08MShares held
$959.13MReported value
+1New positions
−0Exits
Momentum inputs (comparable managers):
holder breadth +6.7% ·
share flow +0.6% ·
net new positions +6.2%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +12 | 31.81M | $4.18B | +21 | −9 |
| Q1 2026 | 96 | +7 | 41.18M | $3.45B | +13 | −6 |
| Q4 2025 | 88 | 0 | 38.24M | $2.89B | — | — |
| Q3 2025 | 17 | -2 | 25.40M | $1.01B | — | −2 |
| Q2 2025 | 16 | +1 | 22.08M | $959.13M | +1 | — |
| Q1 2025 | 12 | -1 | 10.37M | $387.41M | — | −1 |
| Q4 2024 | 13 | +4 | 9.16M | $415.03M | +4 | — |
| Q3 2024 | 8 | -5 | 7.45M | $437.40M | — | −5 |
| Q2 2024 | 13 | — | 6.20M | $244.16M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 6.91M | — | $299.98M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 6.91M | — | $299.98M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 6.91M | — | $299.98M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 6.91M | — | $299.98M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.81M | -30.6% | $165.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.81M | -30.6% | $165.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.81M | -30.6% | $165.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.81M | -30.6% | $165.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 3.81M | -30.6% | $165.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 3.81M | -30.6% | $165.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Wellington Management ✦ | 3.81M | -30.6% | $165.28M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passive) | 2.56M | — | $111.29M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passive) | 2.11M | — | $91.59M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (passive) | 2.11M | — | $91.59M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | The Vanguard Group ✦ (passive) | 2.11M | — | $91.59M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | The Vanguard Group ✦ (passive) | 2.11M | — | $91.59M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | The Vanguard Group ✦ (passive) | 2.11M | — | $91.59M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Adage Capital Partners ✦ | 1.29M | +77.5% | $56.04M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 31 | State Street Global Advisors ✦ (passive) | 1.26M | -4.2% | $54.69M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 32 | Point72 Asset Management ✦ | 1.23M | +213.5% | $53.44M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 33 | Geode Capital Management ✦ (passive) | 782.64K | -6.3% | $33.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Geode Capital Management ✦ (passive) | 782.64K | -6.3% | $33.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 760.84K | -7.4% | $33.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | T. Rowe Price ✦ | 760.84K | -7.4% | $33.05M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Citadel Advisors ✦ | 495.66K | +648.9% | $21.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 38 | Millennium Management ✦ | 245.13K | -5.8% | $10.65M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 194.53K | +2116.6% | $8.45M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Capital World Investors ✦ | 193.90K | 0.0% | $8.42M | 0.0% | Held | 3 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 115.69K | -54.1% | $5.02M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | Marshall Wace ✦ | 90.57K | +680.8% | $3.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Marshall Wace ✦ | 90.57K | +680.8% | $3.93M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | Renaissance Technologies ✦ | 41.10K | New | $1.78M | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $1.78M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 224 holders, 77.95M shares, $5.58B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Jul 08
SC 13G/A — T. Rowe Price Investment Management…
Jul 08
SC 13G/A — WELLINGTON MANAGEMENT GROUP LLP
Jul 08
SC 13G/A — FMR LLC
Jun 23
SC 13D/A — Fairmount Funds Management LLC
9.8% of class · View original SEC filing ↗
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API